Rebecca L Bungay

7PUBLICATIONS
15CO-AUTHORS
Satisfiability and optimisationEpidemiological modellingAsian cultural studiesEpidemiological methodsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study.

|Jan 29, 2026
Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathy.

Arun B Jesudian, Patrick Gagnon-Sanschagrin, Rebecca Bungay

|May 14, 2025
Agitation in individuals with Alzheimer's disease: An assessment of behaviors using the cohen-mansfield agitation inventory in community-dwellers and impact on caregiver experience.

George Grossberg, Cynthia Willey, Christy Houle

|Apr 15, 2024
Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.

Brian E Lacy, Patrick Gagnon-Sanschagrin, Zeev Heimanson

|Apr 11, 2024
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder.

Jeff Schein, Martin Cloutier, Rebecca Bungay

|Sep 04, 2023
Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs.

Arun B Jesudian, Patrick Gagnon-Sanschagrin, Zeev Heimanson

Pageof 2

Frequent Collaborators

2 joint publications

Patrick Gagnon-Sanschagrin

2 joint publications

Marjolaine Gauthier-Loiselle

1 joint publications

Arun B Jesudian

1 joint publications

Ankur A Dashputre